The variable association between expression and methylation of estrogen receptors and the survival of patients with different tumors.

Our pan-cancer analysis data indicated that ERs might be significantly associated with carcinogenesis and progression of some tumors, which may be potential therapeutic targets and prognosis biomarkers.